CGD: "Modelling the Manufacturing Process for COVID-19 Vaccines: Our Approach"

Fascinating insight and analytics by CGD which takes stock of the 200 vaccine candidates against the array of manufacturing facilities available worldwide:

We are developing a system of interconnected models which represent global manufacturing capability from the start of clinical trials to secondary vaccine manufacture.

This tremendous data collection and analysis effort combined with innovative modelling design aims at fine tuning the estimates for vaccine availability and use at population level.

A net contribution to the global good worth reading on the CGD website: Click here.


For adding comments please sign up or log in